Coronary risk in relation to genetic variation in MEOX2 and TCF15 in a Flemish population

[1]  Ira Tabas,et al.  Recent insights into the cellular biology of atherosclerosis , 2015, The Journal of cell biology.

[2]  O. Franco,et al.  Incremental predictive value of 152 single nucleotide polymorphisms in the 10-year risk prediction of incident coronary heart disease: the Rotterdam Study. , 2015, International journal of epidemiology.

[3]  A. Luttun,et al.  Meox2/Tcf15 Heterodimers Program the Heart Capillary Endothelium for Cardiac Fatty Acid Uptake , 2015, Circulation.

[4]  H. Struijker‐Boudier,et al.  Inactive matrix Gla protein is causally related to adverse health outcomes: a Mendelian randomization study in a Flemish population. , 2015, Hypertension.

[5]  Xi-Long Zheng,et al.  Lipoprotein lipase: from gene to atherosclerosis. , 2014, Atherosclerosis.

[6]  Ross M. Fraser,et al.  A General Approach for Haplotype Phasing across the Full Spectrum of Relatedness , 2014, PLoS genetics.

[7]  Guillaume Blin,et al.  Tcf15 Primes Pluripotent Cells for Differentiation , 2013, Cell reports.

[8]  Anne-Sophie Armand,et al.  Mef2d Acts Upstream of Muscle Identity Genes and Couples Lateral Myogenesis to Dermomyotome Formation in Xenopus laevis , 2012, PloS one.

[9]  J. Danesh,et al.  Large-scale association analysis identifies new risk loci for coronary artery disease , 2013 .

[10]  Udo Hoffmann,et al.  A Genetic Risk Score Is Associated With Incident Cardiovascular Disease and Coronary Artery Calcium: The Framingham Heart Study , 2012, Circulation. Cardiovascular genetics.

[11]  Jean-Baptiste Cazier,et al.  Large Scale Association Analysis Identifies Three Susceptibility Loci for Coronary Artery Disease , 2011, PloS one.

[12]  N. Mehta.  Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. , 2011, Circulation. Cardiovascular genetics.

[13]  Erika Salvi,et al.  Genes Involved in Vasoconstriction and Vasodilation System Affect Salt-Sensitive Hypertension , 2011, PloS one.

[14]  J. Staessen,et al.  Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. , 2011, JAMA.

[15]  Thomas W. Mühleisen,et al.  Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease , 2011, Nature Genetics.

[16]  L. Peltonen,et al.  A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses , 2010, The Lancet.

[17]  M. Fornage,et al.  Associations of Lipoprotein Lipase Gene Polymorphisms With Longitudinal Plasma Lipid Trends in Young Adults: The Coronary Artery Risk Development in Young Adults (CARDIA) Study , 2010, Circulation. Cardiovascular genetics.

[18]  M. Cantile,et al.  Homeobox genes in normal and abnormal vasculogenesis. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[19]  D. Gorski,et al.  Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. , 2008, Blood.

[20]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[21]  K. Dickstein,et al.  How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. , 2007, European heart journal.

[22]  William C. Aird,et al.  Phenotypic Heterogeneity of the Endothelium: I. Structure, Function, and Mechanisms , 2007, Circulation research.

[23]  William C Stanley,et al.  Myocardial substrate metabolism in the normal and failing heart. , 2005, Physiological reviews.

[24]  D. Brutsaert,et al.  New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. , 2002, Circulation.

[25]  Dale R. Nyholt,et al.  Genetic case-control association studies – correcting for multiple testing , 2001, Human Genetics.

[26]  J. Staessen,et al.  Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population , 2001, Journal of hypertension.

[27]  B. Nordestgaard,et al.  Lipoprotein Lipase Mutations, Plasma Lipids and Lipoproteins, and Risk of Ischemic Heart Disease A Meta-Analysis , 1999 .

[28]  A. Tybjaerg-hansen,et al.  Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis. , 1999, Circulation.

[29]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[30]  J. Widimský,et al.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus , 1998, Diabetes Care.

[31]  G. Jensen,et al.  Heterozygous lipoprotein lipase deficiency: frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease. , 1997, Circulation.

[32]  A. Mahfoudi,et al.  p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. , 1997, Genes & development.

[33]  G. Lyons,et al.  Embryonic expression of the Gax homeodomain protein in cardiac, smooth, and skeletal muscle. , 1997, Circulation research.

[34]  I. Goldberg.  Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. , 1996, Journal of lipid research.

[35]  J. Isner,et al.  Expression of gax, a Growth Arrest Homeobox Gene, Is Rapidly Down-regulated in the Rat Carotid Artery during the Proliferative Response to Balloon Injury (*) , 1995, The Journal of Biological Chemistry.

[36]  D. Celermajer,et al.  Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. , 1994, Journal of the American College of Cardiology.

[37]  E. Nabel,et al.  Epicardial coronary artery responses to acetylcholine are impaired in hypertensive patients. , 1992, Circulation research.

[38]  A. B. Hill.  The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.

[39]  W. Elliott.  Fatal and Nonfatal Outcomes, Incidence of Hypertension, and Blood Pressure Changes in Relation to Urinary Sodium Excretion , 2012 .

[40]  G. Block,et al.  Will genetics revolutionize medicine? , 2000, The New England journal of medicine.

[41]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .